• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OWLS 验证:一种用于测量初级保健中处方类阿片使用障碍的筛查工具。

Validation of the OWLS, a Screening Tool for Measuring Prescription Opioid Use Disorder in Primary Care.

机构信息

Monash Addiction Research Centre, Monash University Peninsula Campus, Frankston, Victoria, Australia.

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia.

出版信息

Pain Med. 2020 Nov 1;21(11):2757-2764. doi: 10.1093/pm/pnaa275.

DOI:10.1093/pm/pnaa275
PMID:32869062
Abstract

OBJECTIVE

The OWLS is a screening tool for prescription opioid use disorder designed for use in primary care. This study aimed to confirm the optimal wording, scoring methods, and cutoff for the OWLS.

DESIGN AND SETTING

Cross-sectional analysis of an online sample.

SUBJECTS

Participants comprised those with chronic noncancer pain who regularly used prescription opioids.

METHODS

Eligible participants self-completed an online version of the OWLS prescription opioid use disorder screening tool and the Composite International Diagnostic Interview Substance Abuse module. Receiver operating characteristics were calculated for three scoring methods for the OWLS, and these were compared with DSM-5 classification of any use disorder and moderate to severe opioid use disorder.

RESULTS

Among the sample (N = 324), utilizing scoring method (i) (i.e., positive endorsement ≥ response option "a little bit") and a cutoff of 3 increased the percentage of correctly classified participants, with concurrent increases in specificity and decreases in false discovery rate, and false positive rate.

CONCLUSION

OWLS utilizing scoring method (i) with a cutoff of 3 was shown to be the optimal version and scoring method of this tool. This represents a time-efficient, simple scoring method, allowing for quick and accurate screening for opioid use disorder to occur.

摘要

目的

OWLS 是一种专为初级保健设计的处方阿片类药物使用障碍筛查工具。本研究旨在确认 OWLS 的最佳措辞、评分方法和截断值。

设计和设置

横断面分析在线样本。

受试者

研究对象为慢性非癌症疼痛且经常使用处方阿片类药物的患者。

方法

符合条件的参与者自行完成在线版 OWLS 处方阿片类药物使用障碍筛查工具和复合国际诊断访谈物质滥用模块。计算了 OWLS 的三种评分方法的受试者工作特征,并将其与 DSM-5 任何使用障碍和中重度阿片类药物使用障碍的分类进行比较。

结果

在样本(N=324)中,使用评分方法(i)(即,阳性认可≥“有点”)和截断值为 3 可提高正确分类参与者的百分比,同时特异性增加,假阳性率和误报率降低。

结论

OWLS 使用评分方法(i),截断值为 3,被证明是该工具的最佳版本和评分方法。这代表了一种高效、简单的评分方法,能够快速准确地进行阿片类药物使用障碍筛查。

相似文献

1
Validation of the OWLS, a Screening Tool for Measuring Prescription Opioid Use Disorder in Primary Care.OWLS 验证:一种用于测量初级保健中处方类阿片使用障碍的筛查工具。
Pain Med. 2020 Nov 1;21(11):2757-2764. doi: 10.1093/pm/pnaa275.
2
Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care Settings.开发一种用于初级保健环境的简短患者管理处方阿片类药物依赖筛查工具。
Pain Med. 2020 Feb 1;21(2):e79-e88. doi: 10.1093/pm/pnz213.
3
Prevalence and Detection of Prescription Opioid Misuse and Prescription Opioid Use Disorder Among Emergency Department Patients 50 Years of Age and Older: Performance of the Prescription Drug Use Questionnaire, Patient Version.50岁及以上急诊科患者中处方阿片类药物滥用及处方阿片类药物使用障碍的患病率与检测:患者版处方药使用问卷的性能
Am J Geriatr Psychiatry. 2016 Aug;24(8):627-636. doi: 10.1016/j.jagp.2016.03.010. Epub 2016 Apr 1.
4
Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain.诊断使用阿片类药物治疗慢性疼痛的患者中的处方阿片类药物使用障碍。
Am J Psychiatry. 2022 Oct;179(10):715-725. doi: 10.1176/appi.ajp.21070721. Epub 2022 Jun 15.
5
Withdrawal symptoms predict prescription opioid dependence in chronic pain patients.戒断症状可预测慢性疼痛患者处方阿片类药物依赖。
Drug Alcohol Depend. 2019 Feb 1;195:27-32. doi: 10.1016/j.drugalcdep.2018.11.013. Epub 2018 Dec 3.
6
Validity and Reliability of the Computer-Administered Routine Opioid Outcome Monitoring (ROOM) Tool.计算机管理的常规阿片类药物结果监测(ROOM)工具的有效性和可靠性
Pain Med. 2020 Dec 25;21(12):3645-3654. doi: 10.1093/pm/pnaa297.
7
The Adjective Rating Scale for Withdrawal: Validation of its ability to assess severity of prescription opioid misuse.阿片类处方药滥用严重程度评估形容词评定量表:验证其评估能力。
Eur J Pain. 2019 Feb;23(2):307-315. doi: 10.1002/ejp.1305. Epub 2018 Sep 11.
8
Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study.服用阿片类药物治疗慢性非癌性疼痛患者中药物性阿片类物质使用障碍与依赖定义之间的一致性研究(POINT):一项队列研究
Lancet Psychiatry. 2015 Apr;2(4):314-22. doi: 10.1016/S2215-0366(15)00005-X. Epub 2015 Mar 31.
9
Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).在初级保健中识别处方阿片类药物使用障碍:当前阿片类药物滥用衡量标准(COMM)的诊断特征。
Pain. 2011 Feb;152(2):397-402. doi: 10.1016/j.pain.2010.11.006. Epub 2010 Dec 21.
10
Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.简明疼痛问卷在接受美沙酮维持治疗的阿片类药物成瘾患者中的效用。
Pain Physician. 2016 Jan;19(1):E181-95.

引用本文的文献

1
Implementation of screening and assessment tools for diagnosing opioid use disorder: A systematic review.用于诊断阿片类物质使用障碍的筛查和评估工具的实施:一项系统评价
Drug Alcohol Depend Rep. 2025 Aug 20;16:100375. doi: 10.1016/j.dadr.2025.100375. eCollection 2025 Sep.
2
An evidence-based digital prescription opioid safety toolkit for national dissemination: co-design and user testing.用于全国推广的基于证据的数字处方阿片类药物安全工具包:联合设计与用户测试
Front Digit Health. 2025 Jul 11;7:1600836. doi: 10.3389/fdgth.2025.1600836. eCollection 2025.
3
Predictive Models for Identifying Adult Patients at High Risk of Developing Opioid-Related Harms: a Systematic Review.
识别有阿片类药物相关伤害高风险成年患者的预测模型:一项系统综述
Drug Saf. 2025 May 28. doi: 10.1007/s40264-025-01563-4.
4
Using AI to screen for opioid use disorder.使用人工智能筛查阿片类药物使用障碍。
Nat Med. 2025 Apr 17. doi: 10.1038/s41591-025-03673-z.
5
Substance Use Disorder and Suicidal Ideation in Rural Maryland.马里兰州农村地区的物质使用障碍与自杀意念
Chronic Stress (Thousand Oaks). 2024 Aug 6;8:24705470241268483. doi: 10.1177/24705470241268483. eCollection 2024 Jan-Dec.
6
Identifying Prescription-Opioid-Related Risks Using Prescription Drug Monitoring Programs' Algorithms and Clinical Screening Tools.使用处方药监测程序算法和临床筛查工具识别与处方阿片类药物相关的风险。
Pharmacy (Basel). 2023 Oct 13;11(5):164. doi: 10.3390/pharmacy11050164.
7
Algorithms to Identify Nonmedical Opioid Use.识别非医疗用途阿片类药物使用的算法。
Curr Pain Headache Rep. 2023 May;27(5):81-88. doi: 10.1007/s11916-023-01104-7. Epub 2023 Apr 6.